Named on 5 rounds in the feed, most often at Series C and in Biotech.
Rounds from 2023-03-22 to 2026-06-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Flare Therapeutics A biotech startup targeting transcription factors | Series C Verified against 5 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $85M | 2026-06-30 | [ PART ] |
Stipple Bio Stipple Bio develops targeted oncology therapies through precision mapping of tumor-specific epitopes for cancer treatment. | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-04-06 | [ PART ] |
Soley Therapeutics Soley Therapeutics is a biotech company that discovers and develops novel medicines by leveraging the sensing capabilities of human cells. | Series C Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2026-01-07 | [ PART ] |
STAR Therapeutics They develop and provide antibody therapies for patients with serious diseases. | Series D Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $125M | 2025-09-30 | [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ LEAD ] |